药物发现外包服务市场-按服务类型（化学、生物）、挖掘类型（小分子和大分子）、疾病模型（体外、细胞和动物模型）、治疗领域（糖尿病、神经病学、肿瘤学）、全球预测(2023-2032)

由于基因疗法和单株抗体等生物製剂的快速发展，药物发现外包服务市场规模从 2023 年到 2032 年的复合年增长率预计将达到 8.2%。

为了满足个别患者的需求，新型生物製剂和个人化医疗解决方案的蓬勃发展导致生物製药研发活动对外包服务的需求更大。举个例子，2021年1月，Charles River Laboratories International与生物製药服务提供者JADE Biomedical合作，扩大其全球生物製剂测试能力，同时满足生物製剂治疗（主要是细胞和基因疗法）的需求。外包提供者对服务的日益关注，例如现实世界的证据生成以及以患者为中心的试验设计，以提高临床研究的效率，也将有助于市场的成长。

药物发现外包服务业根据服务类型、药物类型、疾病模型、治疗领域和区域进行细分。

从服务类型来看，2023-2032年化学服务领域的市场规模将录得可观的复合年增长率。药物发现外包化学服务在製药和生物技术行业简化和加快药物开发过程中发挥关键作用。外包计算化学服务以满足虚拟筛选、分子建模和基于结构的药物设计等用途的重要性日益凸显，也将有助于该领域的成长。

以治疗领域为基础，神经病学领域的药物发现外包服务产业价值预计将扩大到2032年。这一增长可归因于阿兹海默症、帕金森氏症和多发性硬化症的更高负担以及随后的需求开发有效的治疗方法。外包神经病学药物发现服务的一些优点包括加速研发活动、降低成本以及更容易获得专业知识。

从地区来看，由于存在庞大的人才库、具有成本效益的劳动力和有利的监管环境，预计到 2032 年，亚太地区药物发现外包服务市场规模将出现显着的复合年增长率。对降低成本、获取专业知识和加速药物开发过程的日益增长的需求迫使许多製药和生物技术公司转向外包药物发现服务。与智慧财产权、临床试验和资料安全相关的不断变化的监管环境也将促进区域产业的成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：药物发现外包服务业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 全球慢性病盛行率不断上升
    • 对外包新药和疗法的需求不断增加
    • 製药和生技公司增加研发支出
    • 药物发现的技术不断进步
  • 产业陷阱与挑战
    • 智慧财产权问题
• 成长潜力分析
• COVID-19 影响分析
• 监管环境
  • 我们
  • 欧洲
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
  • Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
  • Laboratory Corporation of America Holdings (Covance Inc.)
  • IQVIA (Quintiles IMS Holdings, Inc.)
  • Eurofins Scientific
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：药物发现外包服务市场：依服务类型，2018 - 2032

• 主要动向：依服务类型
• 化学服务
• 生物服务

第 6 章：药物发现外包服务市场：依药物类型，2018 - 2032

• 主要动向：依药物类型
• 小分子药物
• 大分子药物

第 7 章：药物发现外包服务市场：依疾病模型，2018 - 2032

• 主要动向：依疾病模型
• 体外模型
• 动物模型
• 蜂窝模型
• 其他疾病模型

第 8 章：药物发现外包服务市场：依治疗领域，2018 - 2032

• 主要动向：依治疗领域
• 糖尿病
• 神经病学
• 肿瘤学
• 传染性疾病
• 其他治疗领域

第 9 章：药物发现外包服务市场：按地区划分，2018 - 2032

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 10 章：公司简介

• Charles River Laboratories International, Inc.
• IQVIA (Quintiles IMS Holdings, Inc.)
• Laboratory Corporation of America Holdings (Covance Inc.)
• Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
• WuXi AppTec
• Eurofins Scientific
• GenScript ProBio (Genscript Biotech Corporation)
• Aragen Life Sciences Ltd.
• Syngene International Limited
• Aurigene Pharmaceutical Services Ltd.
• Pharmaron
• Shanghai ChemPartner
• Jubilant Biosys Ltd (Jubilant Pharmova Limited)

Drug Discovery Outsourcing Services Market size is poised to record 8.2% CAGR from 2023-2032, on account of the rapid advances in biologics, including gene therapies and monoclonal antibodies.

The surging developments in novel biologics and personalized medicine solutions to cater to individual patients is leading to the greater demand for outsourcing services in biopharmaceutical R&D activities. To cite an instance, in January 2021, Charles River Laboratories International partnered with biopharma service provider JADE Biomedical to expand its global biologics testing capabilities while accommodating the demand for biologics therapeutics, mainly cell and gene therapies. The growing focus of outsourcing providers on services, such as real-world evidence generation as well as patient-centric trial designs for improved efficiency of clinical research will also contribute to the market growth.

The drug discovery outsourcing services industry is segmented based on service type, drug type, disease model, therapeutic area, and region.

In terms of service type, the market size from the chemistry services segment will record appreciable CAGR from 2023-2032. Drug discovery outsourcing chemistry services are playing pivotal role in the pharmaceutical and biotechnology industries in streamlining and expediting the drug development process. The surging importance of outsourcing computational chemistry services to cater to uses in virtual screening, molecular modeling, and structure-based drug design will also contribute to the segment growth.

On the basis of therapeutic area, the drug discovery outsourcing services industry value from the neurology segment is projected to expand up to 2032. The growth can be attributed to the higher burden of Alzheimer's disease, Parkinson's disease, and multiple sclerosis along with the subsequent need for the development of their effective treatments. Accelerated R&D activities, reduces costs, and the improved access to specialized expertise are some advantages of outsourcing neurology drug discovery services.

Regionally, the APAC drug discovery outsourcing services market size is projected to observe notable CAGR through 2032 due to the presence of large talent pools, cost-effective labor, and favorable regulatory environments. The surging need for reducing costs, accessing specialized expertise, and accelerating the drug development process has compelled numerous pharmaceutical and biotechnology companies to turn to outsourcing for drug discovery services. The evolving regulatory landscape related to intellectual property, clinical trials, and data security will also add to the regional industry growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Drug discovery outsourcing services industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Service type trends
  • 2.1.4 Drug type trends
  • 2.1.5 Disease model trends
  • 2.1.6 Therapeutic area trends

Chapter 3 Drug Discovery Outsourcing Services Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of chronic diseases globally
    • 3.2.1.2 Increasing demand for outsourcing novel drugs and therapeutics
    • 3.2.1.3 Increasing R&D expenditure by pharmaceutical and biotechnology companies
    • 3.2.1.4 Increasing technological advancements in drug discovery
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Intellectual property concerns
• 3.3 Growth potential analysis
  • 3.3.1 By service type
  • 3.3.2 By drug type
  • 3.3.3 By disease model
  • 3.3.4 By therapeutic area
• 3.4 COVID- 19 impact analysis
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
  • 4.1.2 Laboratory Corporation of America Holdings (Covance Inc.)
  • 4.1.3 IQVIA (Quintiles IMS Holdings, Inc.)
  • 4.1.4 Eurofins Scientific
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategy dashboard, 2022

Chapter 5 Drug Discovery Outsourcing Services Market, By Service Type, 2018 - 2032 (USD Million)

• 5.1 Key trends, by service type
• 5.2 Chemistry services
• 5.3 Biological services

Chapter 6 Drug Discovery Outsourcing Services Market, By Drug Type, 2018 - 2032 (USD Million)

• 6.1 Key trends, by drug type
• 6.2 Small-molecule drugs
• 6.3 Large-molecule drugs

Chapter 7 Drug Discovery Outsourcing Services Market, By Disease Model, 2018 - 2032 (USD Million)

• 7.1 Key trends, by disease model
• 7.2 In vitro models
• 7.3 Animal models
• 7.4 Cellular models
• 7.5 Other disease models

Chapter 8 Drug Discovery Outsourcing Services Market, By Therapeutic Area, 2018 - 2032 (USD Million)

• 8.1 Key trends, by therapeutic area
• 8.2 Diabetes
• 8.3 Neurology
• 8.4 Oncology
• 8.5 Infectious diseases
• 8.6 Other therapeutic areas

Chapter 9 Drug Discovery Outsourcing Services Market, By Region, 2018 - 2032 (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

• 10.1 Charles River Laboratories International, Inc.
• 10.2 IQVIA (Quintiles IMS Holdings, Inc.)
• 10.3 Laboratory Corporation of America Holdings (Covance Inc.)
• 10.4 Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
• 10.5 WuXi AppTec
• 10.6 Eurofins Scientific
• 10.7 GenScript ProBio (Genscript Biotech Corporation)
• 10.8 Aragen Life Sciences Ltd.
• 10.9 Syngene International Limited
• 10.10 Aurigene Pharmaceutical Services Ltd.
• 10.11 Pharmaron
• 10.12 Shanghai ChemPartner
• 10.13 Jubilant Biosys Ltd (Jubilant Pharmova Limited)

Data Tables

• TABLE 1 Market revenue, by service type (2022)
• TABLE 2 Market revenue, by drug type (2022)
• TABLE 3 Market revenue, by disease model (2022)
• TABLE 4 Market revenue, by therapeutic area (2022)
• TABLE 5 Global drug discovery outsourcing services market size, by region, 2018 - 2024 (USD Million)
• TABLE 6 Global drug discovery outsourcing services market size, by region, 2025 - 2032 (USD Million)
• TABLE 7 Global drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 8 Global drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 9 Global drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 10 Global drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 11 Global drug discovery outsourcing services market size, by disease model, 2018 - 2024 (USD Million)
• TABLE 12 Global drug discovery outsourcing services market size, by disease model, 2025 - 2032 (USD Million)
• TABLE 13 Global drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 14 Global drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 15 Industry impact forces
• TABLE 16 Competitive benchmarking of major market players
• TABLE 17 Competitive positioning matrix: Classification criteria
• TABLE 18 Chemistry services market size, 2018 - 2024 (USD Million)
• TABLE 19 Chemistry services market size, 2025 - 2032 (USD Million)
• TABLE 20 Biological services market size, 2018 - 2024 (USD Million)
• TABLE 21 Biological services market size, 2025 - 2032 (USD Million)
• TABLE 22 Small-molecule drugs market size, 2018 - 2024 (USD Million)
• TABLE 23 Small-molecule drugs market size, 2025 - 2032 (USD Million)
• TABLE 24 Large-molecule drugs market size, 2018 - 2024 (USD Million)
• TABLE 25 Large-molecule drugs market size, 2025 - 2032 (USD Million)
• TABLE 26 In vitro models market size, 2018 - 2024 (USD Million)
• TABLE 27 In vitro models market size, 2025 - 2032 (USD Million)
• TABLE 28 Animal models market size, 2018 - 2024 (USD Million)
• TABLE 29 Animal models market size, 2025 - 2032 (USD Million)
• TABLE 30 Cellular models market size, 2018 - 2024 (USD Million)
• TABLE 31 Cellular models market size, 2025 - 2032 (USD Million)
• TABLE 32 Other disease models market size, 2018 - 2024 (USD Million)
• TABLE 33 Other disease models market size, 2025 - 2032 (USD Million)
• TABLE 34 Diabetes market size, 2018 - 2024 (USD Million)
• TABLE 35 Diabetes market size, 2025 - 2032 (USD Million)
• TABLE 36 Neurology market size, 2018 - 2024 (USD Million)
• TABLE 37 Neurology market size, 2025 - 2032 (USD Million)
• TABLE 38 Oncology market size, 2018 - 2024 (USD Million)
• TABLE 39 Oncology market size, 2025 - 2032 (USD Million)
• TABLE 40 Infectious diseases market size, 2018 - 2024 (USD Million)
• TABLE 41 Infectious diseases market size, 2025 - 2032 (USD Million)
• TABLE 42 Other therapeutic areas market size, 2018 - 2024 (USD Million)
• TABLE 43 Other therapeutic areas market size, 2025 - 2032 (USD Million)
• TABLE 44 North America drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 45 North America drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 46 North America drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 47 North America drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 48 North America drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 49 North America drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 50 North America drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 51 North America drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 52 North America drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 53 North America drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 54 U.S. drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 55 U.S. drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 56 U.S. drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 57 U.S. drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 58 U.S. drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 59 U.S. drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 60 U.S. drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 61 U.S. drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 62 Canada drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 63 Canada drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 64 Canada drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 65 Canada drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 66 Canada drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 67 Canada drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 68 Canada drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 69 Canada drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 70 Europe drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 71 Europe drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 72 Europe drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 73 Europe drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 74 Europe drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 75 Europe drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 76 Europe drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 77 Europe drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 78 Europe drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 79 Europe drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 80 Germany drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 81 Germany drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 82 Germany drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 83 Germany drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 84 Germany drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 85 Germany drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 86 Germany drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 87 Germany drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 88 UK drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 89 UK drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 90 UK drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 91 UK drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 92 UK drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 93 UK drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 94 UK drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 95 UK drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 96 France drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 97 France drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 98 France drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 99 France drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 100 France drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 101 France drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 102 France drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 103 France drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 104 Italy drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 105 Italy drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 106 Italy drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 107 Italy drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 108 Italy drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 109 Italy drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 110 Italy drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 111 Italy drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 112 Spain drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 113 Spain drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 114 Spain drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 115 Spain drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 116 Spain drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 117 Spain drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 118 Spain drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 119 Spain drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 120 Rest of Europe drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 121 Rest of Europe drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 122 Rest of Europe drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 123 Rest of Europe drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 124 Rest of Europe drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 125 Rest of Europe drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 126 Rest of Europe drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 127 Rest of Europe drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 128 Asia Pacific drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 129 Asia Pacific drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 130 Asia Pacific drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 131 Asia Pacific drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 132 Asia Pacific drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 133 Asia Pacific drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 134 Asia Pacific drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 135 Asia Pacific drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 136 Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 137 Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 138 China drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 139 China drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 140 China drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 141 China drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 142 China drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 143 China drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 144 China drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 145 China drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 146 Japan discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 147 Japan discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 148 Japan discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 149 Japan discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 150 Japan discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 151 Japan discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 152 Japan discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 153 Japan discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 154 India drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 155 India drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 156 India drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 157 India drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 158 India drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 159 India drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 160 India drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 161 India drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 162 Australia drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 163 Australia drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 164 Australia drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 165 Australia drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 166 Australia drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 167 Australia drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 168 Australia drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 169 Australia drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 170 Rest of Asia Pacific drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 171 Rest of Asia Pacific drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 172 Rest of Asia Pacific drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 173 Rest of Asia Pacific drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 174 Rest of Asia Pacific drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 175 Rest of Asia Pacific drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 176 Rest of Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 177 Rest of Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 178 Latin America drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 179 Latin America drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 180 Latin America drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 181 Latin America drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 182 Latin America drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 183 Latin America drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 184 Latin America drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 185 Latin America drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 186 Latin America drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 187 Latin America drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 188 Brazil drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 189 Brazil drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 190 Brazil drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 191 Brazil drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 192 Brazil drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 193 Brazil drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 194 Brazil drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 195 Brazil drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 196 Mexico discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 197 Mexico discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 198 Mexico discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 199 Mexico discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 200 Mexico discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 201 Mexico discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 202 Mexico discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 203 Mexico discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 204 Rest of Latin America drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 205 Rest of Latin America drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 206 Rest of Latin America drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 207 Rest of Latin America drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 208 Rest of Latin America drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 209 Rest of Latin America drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 210 Rest of Latin America drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 211 Rest of Latin America drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 212 Middle East & Africa drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 213 Middle East & Africa drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 214 Middle East & Africa drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 215 Middle East & Africa drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 216 Middle East & Africa drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 217 Middle East & Africa drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 218 Middle East & Africa drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 219 Middle East & Africa drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 220 Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 221 Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 222 South Africa drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 223 South Africa drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 224 South Africa drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 225 South Africa drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 226 South Africa drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 227 South Africa drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 228 South Africa drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 229 South Africa drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 230 Saudi Arabia discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 231 Saudi Arabia discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 232 Saudi Arabia discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 233 Saudi Arabia discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 234 Saudi Arabia discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 235 Saudi Arabia discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 236 Saudi Arabia discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 237 Saudi Arabia discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 238 Rest of Middle East & Africa drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 239 Rest of Middle East & Africa drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 240 Rest of Middle East & Africa drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 241 Rest of Middle East & Africa drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 242 Rest of Middle East & Africa drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 243 Rest of Middle East & Africa drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 244 Rest of Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 245 Rest of Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Profile break-up of primary respondents
• FIG 6 Drug discovery outsourcing services 360 degree synopsis, 2018 - 2032
• FIG 7 Industry ecosystem analysis
• FIG 8 Growth potential analysis, by service type
• FIG 9 Growth potential analysis, by drug type
• FIG 10 Growth potential analysis, by disease model
• FIG 11 Growth potential analysis, by therapeutic area
• FIG 12 Porter's analysis
• FIG 13 PESTEL analysis
• FIG 14 Company matrix analysis, 2022
• FIG 15 Competitive analysis of major market players
• FIG 16 Competitive positioning matrix, 2022
• FIG 17 Strategy dashboard, 2022